PharmacoEconomics & Outcomes News

, Volume 828, Issue 1, pp 2–2 | Cite as

FDA guidance on interchangeable biological products

News item


  1. Statement from Acting FDA Commissioner Ned Sharpless, M.D., on policy advancements to help bring interchangeable biosimilars to market. Internet Document : 15 May 2019. Available from: URL:

Copyright information

© Springer International Publishing AG 2019

Personalised recommendations